Facebook Twitter Google Plus Vimeo Youtube Feed Feedburner

ROS LBoard 1

A better chance for cancer victims

A Cuban discovery lessens the side effects of treatment and increases survival rates.

Cuban scientist who discovered antibodies, Dr Normando Enrique Iznaga-Escobar

Cuban scientist who discovered antibodies, Dr Normando Enrique Iznaga-Escobar

KUALA LUMPUR: Thanks to a discovery made by a Cuban scientist, some cancer patients can now undergo treatment without suffering much of the side effects associated with chemotherapy and radiotherapy.

In 1991, Normando Enrique Iznaga-Escobar developed antibodies that specifically target a certain antigen or toxin found in cancer cells.

The landmark discovery has been clinically tested and, in some cases, has increased cancer survival rates by up to 50%.

The antibodies lessen the side effects of conventional cancer treatments such as nausea and hair loss. They are available in several countries, but have yet to be introduced in Malaysia.

The antibodies, called Nimotuzumab, were extensively tested in more than 29 clinical trials in eight different cancer localisations.

According to Escobar, the combination of external radiation or radio-chemotherapy with Nimotuzumab is effective, safe and increases the overall survival rate of patients with various types and degrees of cancer.

“The antibodies are given after or during the cancer treatment, and they will inhibit the duplication of the cancer cells in the patient’s body,” he said.

“In Japan, 40 cancer patients with stage three lung cancer were given the antibodies and after five years, more than half are still alive today.”

Escobar said he hoped the antibodies could be distributed in Malaysia soon.

He was speaking after the launch of Latin American Business Day 2017 here. The event was co-organised by the International Trade and Industry Ministry, the Malaysian External Trade Development Corporation and 10 Latin American embassies in Malaysia – Argentina, Brazil, Chile, Colombia, Cuba, Ecuador, Mexico, Peru, Uruguay and Venezuela.


Readers are required to have a valid Facebook account to comment on this story. We welcome your opinions to allow a healthy debate. We want our readers to be responsible while commenting and to consider how their views could be received by others. Please be polite and do not use swear words or crude or sexual language or defamatory words. FMT also holds the right to remove comments that violate the letter or spirit of the general commenting rules.

The views expressed in the contents are those of our users and do not necessarily reflect the views of FMT.